Cue Health to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 31 2024 - 4:01PM
Business Wire
Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology
company, announced today that its management team will participate
at the BTIG MedTech, Digital Health, Life Science & Diagnostic
Tools Conference on Tuesday, February 13, 2024.
About Cue Health
Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology
company that uses diagnostic-enabled care to empower people to live
their healthiest lives. The Cue Health platform offers individuals
and healthcare providers convenient and personalized access to
lab-quality diagnostic tests at home and at the point-of-care, as
well as on-demand telehealth consultations and treatment options
for a wide range of health and wellness needs. Cue’s customers
include federal and state public sector agencies and the private
sector, which includes healthcare providers, enterprises, and
individual consumers. Cue received De Novo authorization from the
U.S. Food and Drug Administration (FDA) for its COVID-19 test,
which became the first home use respiratory test to receive this
FDA approval. Cue also received Emergency Use Authorization from
the FDA for its molecular Mpox test at the point-of-care. Cue,
founded in 2010, owns over 100 patents and is headquartered in San
Diego. For more information, please visit www.cuehealth.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240131854025/en/
Press Cue Health press@cuehealth.com
Investors ICR Westwicke Caroline Corner +1-415-202-5678
caroline.corner@westwicke.com
Cue Health (NASDAQ:HLTH)
Historical Stock Chart
From Apr 2024 to May 2024
Cue Health (NASDAQ:HLTH)
Historical Stock Chart
From May 2023 to May 2024